Page 27 - Quantitative Imaging of Small Tumours with Positron Emission Tomography

Chapter 1 49. Jansen BHE, Yaqub M, Voortman J, et al. Simplified Methods for Quantification of (18)F-DCFPyL Uptake in Patients with Prostate Cancer. J Nucl Med. 2019. 50. Uprimny C, Kroiss AS, Decristoforo C, et al. (68)Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44:941-949. 51. Gorin MA, Rowe SP, Patel HD, et al. Prostate Specific Membrane Antigen Targeted (18)F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study. J Urol. 2018;199:126-132. 52. Morris ED, Endres CJ, Schmidt KC, Christian BT, Muzic RF, Fisher RE. Kinetic modeling in positron emission tomography. Emission Tomography: The Fundamentals of PET and SPECT Academic, San Diego. 2004. 53. Kramer GM, Yaqub M, Vargas HA, et al. Assessment of simplified methods for quantification of (18) F-FDHT uptake in patients with metastatic castration-resistant prostate cancer. J Nucl Med. 2019. 54. Lubberink M, Direcks W, Emmering J, et al. Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer. Mol Imaging Biol. 2012;14:777-782. 55. Badawi RD, Shi H, Hu P, et al. First Human Imaging Studies with the EXPLORER Total-Body PET Scanner. J Nucl Med. 2019;60:299-303. 56. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519- 1527. 57. Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441-446. 58. De Bernardi E, Buda A, Guerra L, et al. Radiomics of the primary tumour as a tool to improve (18) F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer. EJNMMI Res. 2018;8:86. 59. Li K, Sun H, Lu Z, et al. Value of [(18)F]FDG PET radiomic features and VEGF expression in predicting pelvic lymphatic metastasis and their potential relationship in early-stage cervical squamous cell carcinoma. Eur J Radiol. 2018;106:160-166. 60. Cook GJR, Azad G, Owczarczyk K, Siddique M, Goh V. Challenges and Promises of PET Radiomics. Int J Radiat Oncol Biol Phys. 2018;102:1083-1089. 61. Parmar C, Grossmann P, Bussink J, Lambin P, Aerts H. Machine Learning methods for Quantitative Radiomic Biomarkers. Sci Rep. 2015;5:13087. 62. Pfaehler E, De Jong JR, Dierckx R, van Velden FHP, Boellaard R. SMART (SiMulAtion and ReconsTruction) PET: an efficient PET simulation-reconstruction tool. EJNMMI Phys. 2018;5:16. 63. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945. 64. Erlandsson K, Buvat I, Pretorius PH, Thomas BA, Hutton BF. A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Phys Med Biol. 2012;57:R119-159. 65. Hotta M, Minamimoto R, Yano H, Gohda Y, Shuno Y. Diagnostic performance of (18)F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI. Cancer Imaging. 2018;18:4. 66. Lasnon C, Hicks RJ, Beauregard JM, et al. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer. Clin Nucl Med. 2012;37:971- 976. 67. Bellevre D, Blanc Fournier C, Switsers O, et al. Staging the axilla in breast cancer patients with (1) (8)F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems? Eur J Nucl Med Mol Imaging. 2014;41:1103-1112. 68. Kawashima K, Kato K, Tomabechi M, et al. Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer. Br J Radiol. 2016;89:20150938. 69. Groheux D, Quere G, Blanc E, et al. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review. Diagn Interv Imaging. 2016;97:1003-1017. 70. Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol. 2001;19:414-419. 26